Sep 11, 2012
1:5
For every 5 shares held, investors received 1.
The split itself did not change the total investment value.
ABATTIS BIOCEUTICALS CORP (OTC:ATTBF) operates in the Pharmaceuticals: major industry.
ABATTIS BIOCEUTICALS CORP company overviewABATTIS BIOCEUTICALS CORP's most recent stock split was on September 11, 2012. It was a 1-for-5 reverse split, so shareholders received 1 share for every 5 they held.
ABATTIS BIOCEUTICALS CORP has split its stock once. This history records one reverse split, on September 11, 2012.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In ABATTIS BIOCEUTICALS CORP's 1-for-5 reverse split on September 11, 2012, every 5 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
ABATTIS BIOCEUTICALS CORP has not announced a new split in our records. Its most recent split was on September 11, 2012, 14 years ago. Companies announce splits in advance, and any new OTC:ATTBF split will appear on this page.
Already premium?